Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 249

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

Open access
Park, Young-Jun, Pinto, Dora, Walls, Alexandra C., Liu, Zhuoming, De Marco, Anna, Benigni, Fabio, Zatta, Fabrizia, Silacci-Fregni, Chiara, Bassi, Jessica, Sprouse, Kaitlin R., Addetia, Amin, Bowen, John E., Stewart, Cameron, Giurdanella, Martina, Saliba, Christian, Guarino, Barbara, Schmid, Michael A., Franko, Nicholas M., Logue, Jennifer K., Dang, Ha V., Hauser, Kevin, di Iulio, Julia, Rivera, William, Schnell, Gretja, Rajesh, Anushka, Zhou, Jiayi, Farhat, Nisar, Kaiser, Hannah, Montiel-Ruiz, Martin, Noack, Julia, Lempp, Florian A., Janer, Javier, Abdelnabi, Rana, Maes, Piet, Ferrari, Paolo, Ceschi, Alessandro, Giannini, Olivier, de Melo, Guilherme Dias, Kergoat, Lauriane, Bourhy, Hervé, Neyts, Johan, Soriaga, Leah, Purcell, Lisa A., Snell, Gyorgy, Whelan, Sean P.J., Lanzavecchia, Antonio, Virgin, Herbert W., Piccoli, Luca, Chu, Helen Y., Pizzuto, Matteo Samuele, Corti, Davide, Veesler, David·2022·Science

Published version of a preprint

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages carry distinct spike mutations resulting in escape from antibodies induced by previous infection or vaccination. We show that hybrid immunity or vaccine boosters elicit plasma-neutralizing antibodies against Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5, and that breakthrough infections, but not vaccination alone, induce neutralizing antibodies in the nasal mucosa. Consistent with immunological imprinting, most antibodies derived from memory B cells or plasma cells of Omicron breakthrough cases cross-react with the Wuhan-Hu-1, BA.1, BA.2, and BA.4/5 receptor-binding domains, whereas Omicron primary infections elicit B cells of narrow specificity up to 6 months after infection. Although most clinical antibodies have reduced neutralization of Omicron, we identified an ultrapotent pan-variant–neutralizing antibody that is a strong candidate for clinical development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.adc9127

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 249

Metadata

Authors
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., Addetia, A., Bowen, J. E., Stewart, C., Giurdanella, M., Saliba, C., Guarino, B., Schmid, M. A., Franko, N. M., Logue, J. K., Dang, H. V., Hauser, K., di Iulio, J., Rivera, W., Schnell, G., Rajesh, A., Zhou, J., Farhat, N., Kaiser, H., Montiel-Ruiz, M., Noack, J., Lempp, F. A., Janer, J., Abdelnabi, R., Maes, P., Ferrari, P., Ceschi, A., Giannini, O., de Melo, G. D., Kergoat, L., Bourhy, H., Neyts, J., Soriaga, L., Purcell, L. A., Snell, G., Whelan, S. P. J., Lanzavecchia, A., Virgin, H. W., Piccoli, L., Chu, H. Y., Pizzuto, M. S., Corti, D., & Veesler, D.
Venue
Science
Published
2022-11-11
Volume
378
Issue
6620
Pages
619-627
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4306902076
Cited by
249
References
22
FWCI
25.29
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. https://app.cochat.ai/papers/10.1126/science.adc9127
The paper
Park, Y.-J., Pinto, D., Walls, A. C., Liu, Z., De Marco, A., Benigni, F., Zatta, F., Silacci-Fregni, C., Bassi, J., Sprouse, K. R., Addetia, A., Bowen, J. E., Stewart, C., Giurdanella, M., Saliba, C., Guarino, B., Schmid, M. A., Franko, N. M., Logue, J. K., . . . Veesler, D. (2022). Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science. https://doi.org/10.1126/science.adc9127

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.